UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022007 |
|---|---|
| Receipt number | R000025359 |
| Scientific Title | Phase II trial of nivolumab in patients with unresectable or recurrent thymic carcinoma; PRIMER trial |
| Date of disclosure of the study information | 2016/06/01 |
| Last modified on | 2020/04/23 09:04:46 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/04/20 22:27:57 | ||
| 2 | Update | 2016/07/01 10:08:51 | Recruitment status |
|
| 3 | Update | 2016/07/01 10:09:21 | UMIN ID1 |
|
| 4 | Update | 2017/10/03 20:44:17 | Recruitment status |
|
| 5 | Update | 2019/04/23 09:29:10 | URL related to results and publications Number of participants that the trial has enrolled |
|
| 6 | Update | 2020/04/23 09:04:46 | Recruitment status Date of IRB Last follow-up date |
